| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |